ONCOLOGY EVOLVED WUGEN TECHNOLOGY Latest News Wugen Appoints Daniel Kemp, Ph.D., as Chief Executive Officer April 14, 2021 Press Releases The Development of Natural Killer Cells for Solid Tumor Treatment March 26, 2021 Articles BioWorld: Alpha Biopharma lands deal for Wugen’s memory NK and CAR T cells for Asia March 13, 2021 Articles
